Search results for "insulin"

showing 10 items of 1360 documents

Insulin withdrawal in diabetic kidney disease : What are we waiting for?

2021

The prevalence of type 2 diabetes mellitus worldwide stands at nearly 9.3% and it is estimated that 20–40% of these patients will develop diabetic kidney disease (DKD). DKD is the leading cause of chronic kidney disease (CKD), and these patients often present high morbidity and mortality rates, particularly in those patients with poorly controlled risk factors. Furthermore, many are overweight or obese, due primarily to insulin compensation resulting from insulin resistance. In the last decade, treatment with sodium–glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1-RA) have been shown to be beneficial in renal and cardiovascular targets; however…

Opinionmedicine.medical_specialtyinsulinHealth Toxicology and Mutagenesismedicine.medical_treatmentRenal function030209 endocrinology & metabolism030204 cardiovascular system & hematologyOverweight03 medical and health sciences0302 clinical medicineInsulin resistancecardiovascular diseaseInternal medicinemedicineHumansHypoglycemic AgentsInsulinDiabetic NephropathiesSGLT2iDiabetic kidney diseaseSodium-Glucose Transporter 2 InhibitorsDipeptidyl-Peptidase IV InhibitorsDiabetisbusiness.industryInsulinMortality ratePublic Health Environmental and Occupational HealthRType 2 Diabetes Mellitusmedicine.diseaseRepaglinideCardiovascular diseaseGLP-1RAdiabetic kidney diseaseCor MalaltiesDiabetes Mellitus Type 2Medicinemedicine.symptombusinessKidney diseasemedicine.drug
researchProduct

Indicaxanthin from Opuntia ficus-indica Fruit Ameliorates Glucose Dysmetabolism and Counteracts Insulin Resistance in High-Fat-Diet-Fed Mice

2021

Obesity-related dysmetabolic conditions are amongst the most common causes of death globally. Indicaxanthin, a bioavailable betalain pigment from Opuntia ficus-indica fruit, has been demonstrated to modulate redox-dependent signalling pathways, exerting significant anti-oxidative and anti-inflammatory effects in vitro and in vivo. In light of the strict interconnections between inflammation, oxidative stress and insulin resistance (IR), a nutritionally relevant dose of indicaxanthin has been evaluated in a high-fat diet (HFD) model of obesity-related IR. To this end, biochemical and histological analysis, oxidative stress and inflammation evaluations in liver and adipose tissue were carried…

Opuntia ficus-indicaobesityPhysiologyindicaxanthin; <i>Opuntia ficus-indica</i>; phytochemicals; insulin resistance; obesity; inflammation; oxidative stress; dysmetabolismClinical BiochemistryindicaxanthinCell BiologyRM1-950phytochemicalsBiochemistryDysmetabolism<i>Opuntia ficus-indica</i>Oxidative stressinflammationinsulin resistanceTherapeutics. PharmacologyMolecular BiologyAntioxidants
researchProduct

Response to The Letter “Overadjustment in Regression Analyses: Considerations When Evaluating Relationships Between Body Mass Index, Muscle Strength,…

2014

OrthodonticsAgingmedicine.medical_specialtybusiness.industryta3141Body sizemedicine.diseaseRegressionEndocrinologyInsulin resistanceInternal medicineHand strengthmedicineMuscle strengthGeriatrics and GerontologybusinessBody mass indexJournals of Gerontology Series A: Biological Sciences and Medical Sciences
researchProduct

Polycystic ovary syndrome

2016

Polycystic ovary syndrome (PCOS) affects 5-20% of women of reproductive age worldwide. The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology (PCOM) - with excessive androgen production by the ovaries being a key feature of PCOS. Metabolic dysfunction characterized by insulin resistance and compensatory hyperinsulinaemia is evident in the vast majority of affected individuals. PCOS increases the risk for type 2 diabetes mellitus, gestational diabetes and other pregnancy-related complications, venous thromboembolism, cerebrovascular and cardiovascular events and endometrial cancer. PCOS is a diagnosis of exclusion, based primarily on the p…

OvulationHirsutismmedicine.medical_specialtyendocrine system diseases030209 endocrinology & metabolismOvaryPathogenesis03 medical and health sciences0302 clinical medicineInsulin resistanceSDG 3 - Good Health and Well-beingRisk FactorsInternal medicineAcne VulgarismedicineHumansCongenital adrenal hyperplasiaObesityAbdominal obesityhirsutism030219 obstetrics & reproductive medicinebusiness.industryOvaryHyperandrogenismAlopeciaGeneral Medicinemedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsEndocrinologymedicine.anatomical_structureAndrogensQuality of LifeFemalemedicine.symptomHyperandrogenismbusinessPolycystic Ovary SyndromeNature Reviews Disease Primers
researchProduct

Exenatide improves antioxidant capacity and reduces the expression of LDL receptors and PCSK9 in human insulin-secreting 1.1E7 cell line subjected to…

2022

Abstract Introduction GLP-1 receptor agonists (e.g., exenatide) are novel drugs used in the treatment of diabetes. These drugs, working with other mechanisms of action, improve glycemic control by increasing secretion of insulin and improving survival of pancreatic islet beta cells. Alterations in the oxidative stress level or the expression of proteins associated with cholesterol uptake might be responsible for those findings. Currently, there are few in vitro studies on the impact of exenatide antioxidant capacity in human islet beta cell lines and none that assess the influence of exenatide on LDL receptors and PCSK9 under hyperglycemia and oxidative stress. Therefore, we evaluated the i…

PCSK9Microbiology (medical)insulinInfectious Diseasespancreatic beta cellExenatideoxidative stressLDL receptorGLP-1Postępy Higieny i Medycyny Doświadczalnej
researchProduct

The automated pancreas: A review of technologies and clinical practice

2021

Insulin pumps and glucose sensors are effective in improving diabetes therapy and reducing acute complications. The combination of both devices using an algorithm-driven interoperable controller makes automated insulin delivery (AID) systems possible. Many AID systems have been tested in clinical trials and have proven safety and effectiveness. However, currently, none of these systems are available for routine use in children younger than 6 years in Europe. For continued use, both users and prescribers must have sound knowledge of the features of the individual AID systems. Presently, all systems require various user interactions (e.g. meal announcements) because fully automated systems ar…

Pancreas ArtificialInsulin pumpTelemedicinebusiness.industryBlood Glucose Self-MonitoringEndocrinology Diabetes and MetabolismInteroperabilityHCL; artificial pancreas; automated delivery; closed loop; insulin; insulin AIDCloud computingDiabetes TherapyArtificial pancreasClinical trialInsulin Infusion SystemsEndocrinologyRisk analysis (engineering)Diabetes MellitusInternal MedicineHumansMedicineMetric (unit)ChildbusinessDiabetes, Obesity and Metabolism
researchProduct

Suitability of non-glucose-carbohydrates for parenteral nutrition

1975

Postoperative parenteral nutrition can only be optimally effective if the characteristics of post-traumatic metabolism are taken into account. Two main possibilities are discussed for the carbohydrate component of parenteral nutrition during this phase: glucose with high doses of insulin or non-glucose carbohydrates (sugar substitutes) possibly in a suitable combination with glucose. The risks as well as the technical and organisational problems involved in the use of them are discussed and the authors prefer the second of the two alternatives. Possible side effects of non-glucose carbohydrates are pointed out and it is shown how these can be avoided by observing dose guidelines. So far a c…

Parenteral Nutritionmedicine.medical_treatmentBlood sugarPhysiologyFructoseCarbohydrate metabolismCritical Care and Intensive Care MedicineXylitolElectrolyteschemistry.chemical_compoundPregnancyDietary CarbohydratesmedicineHumansSugarXylitolOxalatesAdenine Nucleotidesbusiness.industryInsulinProteinsBilirubinGeneral MedicineMetabolismCarbohydrateLipid MetabolismUric AcidGlucoseParenteral nutritionBiochemistrychemistryLactatesFemaleParenteral Nutrition TotalbusinessEuropean Journal of Intensive Care Medicine
researchProduct

Diabetes screening by telecentric digital holographic microscopy

2015

Diabetes is currently the world's fastest growing chronic disease and it is caused by deficient production of insulin by the endocrine pancreas or by abnormal insulin action in peripheral tissues. This results in persistent hyperglycaemia that over time may produce chronic diabetic complications. Determination of glycated haemoglobin level is currently the gold standard method to evaluate and control sustained hyperglycaemia in diabetic people. This measurement is currently made by high-performance liquid chromatography, which is a complex chemical process that requires the extraction of blood from the antecubital vein. To reduce the complexity of that measurement, we propose a fully-optica…

Pathologymedicine.medical_specialtyHistologybusiness.industryAntecubital veinInsulinmedicine.medical_treatment030209 endocrinology & metabolismmedicine.disease01 natural sciencesPathology and Forensic Medicine010309 optics03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureDiabetes screeningDiabetes mellitus0103 physical sciencesMicroscopymedicineDigital holographic microscopyPancreasbusinessMass screeningBiomedical engineeringJournal of Microscopy
researchProduct

Ultrasonic demonstration of small pancreatic islet cell tumors.

1982

In three patients real-time sonography successfully localized small pancreatic islet cell tumors measuring 7, 8, and 17 mm in size. Ultrasound is suggested as the initial radiologic examination for localization of endocrine pancreatic tumors. If ultrasound is negative or equivocal, computerized tomography, arteriography, and pancreatic venous sampling are indicated.

Pathologymedicine.medical_specialtybusiness.industryRadiologic examinationUltrasoundMiddle Agedmedicine.diseaseAdenoma Islet CellPancreatic venous samplingPancreatic Neoplasmsmedicine.anatomical_structureEndocrinologyInternal medicinePancreatic islet cell tumorsMedicineHumansRadiology Nuclear Medicine and imagingUltrasonic sensorFemaleInsulinomaEndocrine pancreatic tumorsbusinessPancreasInsulinomaUltrasonographyJournal of clinical ultrasound : JCU
researchProduct

Concerted actions of insulin-like growth factor 1, testosterone, and estradiol on peripubertal bone growth: a 7-year longitudinal study.

2011

A better understanding of how bone growth is regulated during peripuberty is important for optimizing the attainment of peak bone mass and for the prevention of osteoporosis in later life. In this report we used hierarchical models to evaluate the associations of insulin-like growth factor 1 (IGF-1), estradiol (E(2) ), and testosterone (T) with peripubertal bone growth in a 7-year longitudinal study. Two-hundred and fifty-eight healthy girls were assessed at baseline (mean age 11.2 years) and at 1, 2, 3.5, and 7 years. Serum concentrations of IGF-1, E(2) , and T were determined. Musculoskeletal properties in the left lower leg were measured using peripheral quantitative computed tomography …

Peak bone massAdultMalemedicine.medical_specialtyAdolescentEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOsteoporosisBone and BonesInsulin-like growth factorInternal medicinemedicineHumansOrthopedics and Sports MedicineTestosteroneLongitudinal StudiesQuantitative computed tomographyInsulin-Like Growth Factor IChildTestosteroneBone mineralBone growthLegBone Developmentmedicine.diagnostic_testEstradiolbusiness.industryPubertymedicine.diseaseEndocrinologyMenarcheFemalebusinessFollow-Up StudiesJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
researchProduct